Results 131 to 140 of about 123,650 (327)

Risk of unprovoked seizures after discontinuation of antiseizure medication at discharge following acute symptomatic seizures

open access: yesEpilepsia, EarlyView.
Abstract Objective We aimed to investigate whether the risk of unprovoked seizures differs between patients receiving a brief antiseizure medication (ASM) course during hospitalization and those treated beyond hospital discharge following acute symptomatic seizures (ASyS).
Vineet Punia   +7 more
wiley   +1 more source

Inflammatory changes in the choroid plexus following subarachnoid hemorrhage: the role of innate immune receptors and inflammatory molecules

open access: yesFrontiers in Cellular Neuroscience
IntroductionThe choroid plexus is located in the cerebral ventricles. It consists of a stromal core and a single layer of cuboidal epithelial cells that forms the blood-cerebrospinal barrier.
Peter Solár   +11 more
doaj   +1 more source

Epilepsy as a dynamic disease: Toward actionable, individualized seizure risk prediction

open access: yesEpilepsia, EarlyView.
Abstract The current definition of epilepsy allows diagnosis after a single unprovoked seizure if the estimated 10‐year recurrence risk is ≥60%. While this framework is grounded in epidemiological evidence, it does not align with the shorter time horizons that guide many clinical and personal decisions.
Kai Michael Schubert   +3 more
wiley   +1 more source

Standard complete blood count to predict long‐term outcomes in febrile infection–related epilepsy syndrome (FIRES): A multicenter study

open access: yesEpilepsia, EarlyView.
Abstract Objective We investigated whether complete blood count (CBC) analyses during intensive care unit stay could predict 12‐month outcomes in patients with cryptogenic febrile infection–related epilepsy syndrome (FIRES), a subset of new‐onset refractory status epilepticus (NORSE).
Martin Guillemaud   +36 more
wiley   +1 more source

Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors

open access: yesHaemophilia, EarlyView.
Introduction Eptacog beta is an activated recombinant human factor VII bypassing agent approved for treating bleeding episodes (BEs) in patients aged ≥12 years with haemophilia A or B with inhibitors. Two initial dose regimens (IDRs) of either 75 or 225 µg/kg, followed by 75 µg/kg, are approved.
Manuel Carcao   +7 more
wiley   +1 more source

Therapeutic potential of stem cells in subarachnoid hemorrhage

open access: yesNeural Regeneration Research
Aneurysm rupture can result in subarachnoid hemorrhage, a condition with potentially severe consequences, such as disability and death. In the acute stage, early brain injury manifests as intracranial pressure elevation, global cerebral ischemia, acute ...
Hideki Kanamaru, Hidenori Suzuki
doaj   +1 more source

Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Although nimodipine is commonly used to treat reversible cerebral vasoconstriction syndrome (RCVS), its disease‐modifying effects are not yet understood. We prospectively investigated the effect of nimodipine and treatment initiation timing on the prevention of worsened vasoconstriction in patients with angiogram‐proven ...
Soohyun Cho, Minjung Seong, Mi Ji Lee
wiley   +1 more source

Home - About - Disclaimer - Privacy